Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being de... Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease. Mostrar más
- Veligrotug met all primary and secondary endpoints with high statistical significance in THRIVE-2, achieving a week 15 proptosis responder rate (PRR) of 56% (placebo-adjusted PRR of 48%, p <...
- THRIVE-2 global phase 3 clinical trial evaluated efficacy and safety of veligrotug in patients with chronic thyroid eye disease (TED) - - Conference call and webcast to be held Monday, December...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that...
- Reported positive topline phase 3 data for veligrotug from THRIVE in patients with active thyroid eye disease (TED); on track to report topline data from THRIVE-2 in chronic patients in...
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.96 | 5.19199567334 | 18.49 | 19.88 | 18.2 | 1776771 | 19.22224714 | CS |
| 4 | -2.45 | -11.1872146119 | 21.9 | 23.65 | 17.06 | 1741111 | 19.92250976 | CS |
| 12 | -4.72 | -19.5283409185 | 24.17 | 27.2 | 17.06 | 1227637 | 21.33772383 | CS |
| 26 | 7.14 | 58.0016246954 | 12.31 | 27.2 | 11.85 | 1344065 | 19.25852303 | CS |
| 52 | -3.25 | -14.3171806167 | 22.7 | 27.2 | 11.4 | 1153478 | 18.20124133 | CS |
| 156 | -2.07 | -9.61895910781 | 21.52 | 39 | 9.47 | 759025 | 19.83634587 | CS |
| 260 | -1.94 | -9.06965871903 | 21.39 | 39 | 9.47 | 602583 | 19.66527374 | CS |
Monksdream
3 meses hace
it_happens
4 meses hace
power11
4 meses hace
it_happens
4 meses hace
power11
4 meses hace
it_happens
4 meses hace
Monksdream
4 meses hace
Apprentice
3 años hace
Apprentice
3 años hace
crudeoil24
3 años hace
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
